26th January 2022
UK biotech firm, Aptamer Group, successfully floated via IPO on the London AIM at a value of £80million. The York-based company makes synthetic antibodies for pharmaceutical firms including AstraZeneca. Dr Arron Tolley, together with his business partner Dr David Bunka, successfully floated their biotechnology company via IPO in December 2021. It presents such a huge achievement for […]
